Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
BAPTA-AM (AC170)
Cat.#: ASSD-170
Specifications
Description BAPTA-AM is a cell-permeable Ca2+ chelator that can be hydrolyzed by cytosolic esterases. The compound is used for the manipulation of cellular Ca2+ levels. BAPTA analog. Size 25 mg Chemical Name 1,2-Bis(2-aminophenoxy)ethane-N,N,N ',N'-tetraacetic acid tetrakis(acetoxymethyl ester) Molecule Weight 764.68 Molecular formula C34H40N2O18 CAS Number 126150-97-8 PubChem identifier 2293 Purity >95% Solubility Soluble in DMSO (30mM) Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-116 Annexin V-FITC Apoptosis Staining / Detection Kit (AC116) 1 kit, 100 tests inquiry ASSD-187 Quinaldine Red (AC187) 5 g, 25 g, 100 g, 250 g inquiry ASSD-148 Sulforhodamine 101 (AC148) 50 mg, 100 mg inquiry ASSD-200 Ethylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[3-difluoromethyl-4-phosphoanilinamidosuccinic Acid] Diamide (AC200) 500 μg inquiry ASSD-226 Antifade Fluorescence Mounting Medium (hard set) (AC226) 10 mL inquiry ASSD-143 Fluorescently labeled Muscimol TMR-X conjugate (AC143) 1mg inquiry ASSD-140 A2B covalent ligand (AC140) 50 μg inquiry ASSD-161 Methylene Blue (AC161) 50 mg, 1 g inquiry ASSD-149 D-Luciferin sodium salt (AC149) 10 mg, 50 mg, 100 mg inquiry ASSD-112 Propidium Iodide Staining Solution (1mg/ml) in water (AC112) 1 mL inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket